Company research / CI

Cigna Group (CI)

CIK 0001739940 · NYSE · Hospital & Medical Service Plans

  • Sector Finance & Real Estate
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Cigna Group reported revenue of $274.90B. Revenue grew 11.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $282.38B.

Key ratios (year ended 2025-12-31)

3.3%
Operating margin
2.3%
Net margin
15.0%
Return on year-end equity
11.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-09

Headquarters locality: Bloomfield · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$282.38B$274.90B$247.12B$195.26B$180.52B$174.07B$160.40B$153.57B$48.65B$41.81B$39.84B
Cost of Revenue$224.13B$214.99B$182.51B$133.80B$124.83B$117.55B$103.48B$97.67B$4.79B$2.46B$2.47B
Operating Income$9.96B$9.20B$9.42B$8.54B$8.45B$7.94B$8.15B$8.08B$4.16B$3.94B$3.09B
Depreciation & Amortization$2.72B$2.77B$2.77B$3.04B$2.94B$2.92B$2.80B$3.65B$695.00M$566.00M$610.00M
EBITDA$12.68B$11.97B$12.19B$11.57B$11.39B$10.86B$10.96B$11.73B$4.86B$4.51B$3.70B
Net Income$6.98B$6.29B$3.78B$5.37B$6.78B$5.42B$8.49B$5.12B$2.65B$2.23B$1.84B
EPS (Diluted)n/a$22.18$12.12$17.39$21.41$15.75$22.96$13.44$10.54$8.77$7.19
Total Assets$157.08B$157.92B$155.88B$152.76B$143.88B$154.89B$155.45B$155.77B$153.23B$61.76Bn/a
Total Liabilities$114.17B$116.05B$114.64B$106.41B$99.13B$107.70B$105.06B$110.39B$112.15B$48.00Bn/a
Shareholders' Equity$42.91B$41.87B$41.24B$46.24B$44.69B$46.98B$50.33B$45.34B$41.03B$13.71B$13.70B
Cash & Equivalents$6.30B$7.68B$7.55B$7.82B$5.92B$5.08B$10.18B$4.62B$3.85B$2.97B$3.19B
Operating Cash Flow$10.28B$9.60B$10.36B$11.81B$8.66B$7.19B$10.35B$9.48B$3.77B$4.09B$4.03B
Capital Expendituresn/an/an/an/an/an/an/a$1.05B$528.00M$471.00M$461.00M
Free Cash Flown/an/an/an/an/an/an/a$8.44B$3.24B$3.62B$3.56B
Share Repurchases$1.28B$3.62B$7.03B$2.28B$7.61B$7.74B$4.04B$1.99B$342.00M$2.73B$139.00M
Dividends Paid$1.62B$1.61B$1.57B$1.45B$1.38B$1.34B$15.00M$15.00Mn/an/an/a
Shares Outstandingn/a263.46M273.79M292.50M298.68M322.95M354.77M372.53M380.92Mn/an/a
Dividends Per Sharen/a$6.04$5.60$4.92$4.48$4.00$0.04$0.04$0.04$0.04n/a
Weighted Average Diluted Sharesn/a268.56M283.22M296.88M313.06M340.97M368.39M379.82M250.22M255.07M259.65M
EPS (Basic)n/a$22.33$12.25$17.57$21.66$15.89$23.17$13.58$10.69$8.92$7.31

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView